Foghorn Therapeutics Inc. (FHTX)
Drugs • Health Care
Percentage
Change
| Mar 21 | Mar 22 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | |
|---|---|---|---|---|---|---|
Net Income to Common | -87 | -74 | ||||
Net Income | -87 | -74 | ||||
Profit | -87 | -74 | ||||
Net Income Continuing | -87 | -74 | ||||
Pretax Income | -87 | -74 | ||||
Total Non-operating Income | 16 | 12 | ||||
Operating Income | -103 | -86 | ||||
Total Revenue | 23 | 31 | ||||
Total Costs and Expenses | -125 | -117 | ||||
Operating Expenses | -125 | -117 | ||||
Impairment Expense | -2 | -6 | ||||
Research and Development Expenses | -95 | -85 | ||||
Selling, General & Administrative Expenses | -28 | -28 | ||||
Other Operating Expenses | 0 | 2 |